Katharina Glatz

Prof. Dr. Katharina Glatz


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2015 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
HLHeinz Läubli
Heinz Läubli
CBCathrin Balmelli
Cathrin Balmelli
MBMatthias Bossard
Matthias Bossard
OPOtmar Pfister
Otmar Pfister
KGKatharina Glatz
Katharina Glatz
AZAlfred Zippelius
Alfred Zippelius
Antibodies that stimulate the immune system by targeting inhibitory T cell receptors were successfully introduced into oncological practice and are capable to overcome tumor-induced immune evasion. In particular, targeting of the inhibitory receptors CTLA-4 and PD-1 or its ligand PD-L1 have been shown to be beneficial for patients with melanoma, renal cell cancer, non-small cell lung cancer and a growing list of other cancers with impressive response rates. Here, we report a severe, potentially life-threatening side effect of anti-PD-1 immunotherapy with pembrolizumab, which has not been previously described in the literature. A 73-year-old woman with metastatic uveal melanoma treated with pembrolizumab in third line developed severe heart failure due to pembrolizumab-mediated autoimmune myocarditis. Echocardiographic studies revealed a severely impaired left ventricular function with dyssynchrony. All tests for cardiotropic viruses were negative and histological analysis of a myocardial biopsy showed lymphocytic infiltration with a predominance of CD8 positive cells and a reduction of FOXP3 positive regulatory T cells. After initiation of corticosteroids and guideline-conform heart failure therapy, the symptoms rapidly improved and the left ventricular function recovered. While autoimmune myocarditis is a documented side effect of other checkpoint inhibitors, as for example ipilimumab and in one case with anti-PD-L1 antibody, it is not described for anti-PD-1-antibodies like pembrolizumab or nivolumab. As the FDA recently approved both pembrolizumab and nivolumab for melanoma progressing after anti-CTLA-4 treatment with ipilimumab, more patients will soon receive anti-PD-1 therapy. Thus, it is important to be aware of such rare, but severe immune-related adverse events.

9 April 2021 in The Journal of Pathology: Clinical Research
Verified
Journal Article
Open access
PDF file
JHJasmin D Haslbauer
Jasmin D Haslbauer
Alexandar TzankovAlexandar Tzankov
Alexandar Tzankov
KMKirsten D Mertz
Kirsten D Mertz
NSNathalie Schwab
Nathalie Schwab
RNRonny Nienhold
Ronny Nienhold
KGKatharina Glatz
Katharina Glatz
While coronavirus disease 2019 (COVID‐19) primarily affects the respiratory tract, pathophysiological changes of the cardiovascular system remain to be elucidated. We performed a retrospective cardiopathological analysis of the heart and vasculature from 23 autopsies of COVID‐19 patients, comparing the findings with control tissue. Myocardium from autopsies of COVID‐19 patients was categorised into severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) positive (n= 14) or negative (n= 9) based on the presence of viral RNA as determined by reverse transcriptase polymerase chain reaction (RT‐PCR). Control tissue was selected from autopsies without COVID‐19 (n= 10) with similar clinical sequelae. Histological characteristics were scored by ordinal and/or categorical grading. Five RT‐PCR‐positive cases underwentin situhybridisation (ISH) for SARS‐CoV‐2. Patients with lethal COVID‐19 infection were mostly male (78%) and had a high incidence of hypertension (91%), coronary artery disease (61%), and diabetes mellitus (48%). Patients with positive myocardial RT‐PCR died earlier after hospital admission (5 versus 12 days,p < 0.001) than patients with negative RT‐PCR. An increased severity of fibrin deposition, capillary dilatation, and microhaemorrhage was observed in RT‐PCR‐positive myocardium than in negatives and controls, with a positive correlation amongst these factors All cases with increased cardioinflammatory infiltrate, without myocyte necrosis (n= 4) or with myocarditis (n= 1), were RT‐PCR negative. ISH revealed positivity of viral RNA in interstitial cells. Myocardial capillary dilatation, fibrin deposition, and microhaemorrhage may be the histomorphological correlate of COVID‐19‐associated coagulopathy. Increased cardioinflammation including one case of myocarditis was only detected in RT‐PCR‐negative hearts with significantly longer hospitalisation time. This may imply a secondary immunological response warranting further characterisation.

Verified
Journal Article
Open access
PDF file
LRLuca Roma
Luca Roma
TLThomas Lorber
Thomas Lorber
SRSabrina Rau
Sabrina Rau
MBMichael Barrett
Michael Barrett
CECaner Ercan
Caner Ercan
CRChristian Ruiz
Christian Ruiz
Intratumoral heterogeneity and clonal evolution are pivotal in the progression and metastasis of melanoma. However, when combined with variable tumor cellularity, intratumoral heterogeneity limits the sensitivity and accuracy of uncovering a cancer’s clonal evolution. In this study, we combined fluorescence-activated cell sorting (FACS) with whole-exome sequencing (WES) to investigate the clonal composition and evolutionary patterns in seven melanoma biopsies obtained from three patients, each having both primary site and metastatic samples. We employed a multiparameter ploidy sorting approach to isolate tumor populations based on DNA ploidy and melanoma biomarkers (SOX10 or S100), enabling us to investigate clonal evolution with high resolution. Our approach increased the mean tumor purity from 70% (range 19–88%) in unsorted material to 91% (range 87–96%) post-sorting. Our findings revealed significant inter- and intratumor heterogeneity, with one patient exhibiting two genomically distinct clonal tumor populations within a single primary site biopsy, each giving rise to different metastases. Our findings highlight the critical role of intratumoral heterogeneity and clonal evolution in melanoma, especially when analyzing tumor trajectories. The unique combination of multiparameter FACS and WES provides a powerful method for identifying clonal populations and reconstructing clonal evolution. This study provides valuable insights into the clonal architecture of melanoma and lays the groundwork for future research with larger patient groups.

26 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
JGJohannes Griss
Johannes Griss
WBWolfgang Bauer
Wolfgang Bauer
CWChristine Wagner
Christine Wagner
MMMargarita Maurer-Granofszky
Margarita Maurer-Granofszky
MSMartin Simon
Martin Simon
SWStephan N Wagner
Stephan N Wagner
Tumor associated inflammation predicts response to immune checkpoint blockade in human melanoma. Established mechanisms that underlie therapy response and resistance center on anti-tumor T cell responses. Here we show that tumor-associated B cells are vital to tumor associated inflammation. Autologous B cells were directly induced by melanoma conditioned medium, expressed pro- and anti-inflammatory factors, and differentiated towards a plasmablast-like phenotype in vitro. We could identify this phenotype as a distinct cluster of B cells in an independent public single-cell RNA-seq dataset from melanoma tumors. There, plasmablast-like tumor-associated B cells showed expression of CD8+T cell-recruiting chemokines such as CCL3, CCL4, CCL5 and CCL28. Depletion of tumor associated B cells in metastatic melanoma patients by anti-CD20 immunotherapy decreased overall inflammation and CD8+T cell numbers in the human melanoma TME. Conversely, the frequency of plasmablast-like B cells in pretherapy melanoma samples predicted response and survival to immune checkpoint blockade in two independent cohorts. Tumor-associated B cells therefore orchestrate and sustain tumor inflammation, recruit CD8+ T effector cells and may represent a predictor for response and survival to immune checkpoint blockade in human melanoma.